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Background: Adenosine stress cardiac magnetic resonance (CMR) is a non invasive test with high sensitivity for the detection of ischaemic heart 
disease, and is now frequently combined with late gadolinium enhancement (LGE) imaging. This may augment its prognostic accuracy for predicting 
cardiovascular events. Previous studies have failed to appraise the combination of adenosine stress perfusion CMR with LGE for this purpose, and 
generally populations at low risk for cardiovascular events have been assessed. We sought to determine the prognostic value of a normal adenosine 
stress perfusion CMR with LGE in the evaluation of intermediate risk patients.
Methods: This evaluation consisted of 362 consecutive patients referred to a tertiary cardiology centre for a clinically indicated stress perfusion 
CMR (January 2008 to May 2009). Perfusion imaging was obtained at stress (adenosine 140 μg/kg/min) and rest on a 1.5T machine. Late 
enhancement was assessed with dual pass gadolinium (total dose 0.2mmol/kg). A negative test, assessed qualitatively, was defined as the absence 
of both reversible ischemia and LGE. Patient records, hospital databases and national death index were reviewed. Major adverse cardiac events 
(MACE) - death, myocardial infarction, revascularisation or ischaemic hospitalisation - were evaluated over a median follow up of 22 months (IQR 
18-25).
Results: The cohort of 362 patients had a mean age of 62.6 ±11.9 years, 152 (53.1%) male and 94 (32.8%) had a history of previous myocardial 
infarction or PCI. Of the 362, 96 (27%) had a stress perfusion CMR positive for ischemia, 266 (73%) were negative. Of the 266 negative CMR, MACE 
was encountered in only 6 (2%) patients (5 PCI and 1 death due to heart failure). Accordingly a negative stress CMR afforded a freedom from MACE 
of 98%.
Conclusion: In patients at intermediate risk for cardiovascular events, a negative stress perfusion CMR is associated with an excellent prognosis. 
This is consistent with the approximate 1% annualized cardiovascular event rate seen in negative stress imaging with other modalities.
